Impact of vitamin D treatment on 25 hydroxy vitamin D levels and insulin homeostasis in obese African American adolescents in a randomized trial.
J Clin Transl Endocrinol
; 12: 13-19, 2018 Jun.
Article
em En
| MEDLINE
| ID: mdl-29892562
BACKGROUND: Obesity is affecting children in epidemic proportions in the United States with nearly 25% of children being obese. Consequences of obesity including dyslipidemia, type 2 diabetes and cardiovascular disease are leading to morbidity at younger ages. Parallel to the obesity and diabetes epidemics, the prevalence of vitamin D deficiency has reached very high levels and has been associated with insulin resistance and dyslipidemia. Studies exploring the impact of vitamin D repletion on insulin sensitivity and dyslipidemia in children are sparse.The aim of this study was to determine the impact of treatment with vitamin D (ergocalciferol) in obese African American (AA) children on vitamin D levels and insulin secretion and sensitivity. METHODS: This pilot study was conducted in a tertiary care Pediatric Emergency Department (ED). African American obese children (nâ¯=â¯29; 22 female) 13-17â¯y, with 25-hydroxy vitamin D level [25(OH)D] <20â¯ng/ml, were randomized to receive either 50,000â¯IU vitamin D2/week or a placebo for 12â¯weeks. Pre- and post- oral glucose tolerance testing with glucose and insulin levels drawn at 0, 30, 60, 90 and 120â¯min were performed. Pre/post intervention lipid profiles and calcium levels were also evaluated. RESULTS: There was no difference in serum 25(OH)D between groups at baseline. Follow-up 25(OH)D level was greater in the treatment vs. placebo group, and significantly increased from baseline in the treatment group only. However, there was no difference between groups in baseline vs. follow-up insulin- or lipid-related parameters. Follow-up serum 25(OH)D was positively correlated with fasting insulin and high-density lipoprotein (HDL) level in the vitamin D treated group only. CONCLUSION: While serum 25(OH)D levels in obese AA teens increased adequately with vitamin treatment for 12â¯weeks and correlated with fasting insulin, it did not significantly impact insulin secretion or sensitivity. Larger studies are required over a longer period of time to confirm and explore the reasons for this finding.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article